40.7 %The blood groups phenotypes O (40.7%) and A (31.2%) were more frequent with respective allele frequencies of 0.65 and 0.21.
Malipaludismepublished 2019PloS oneeurope_pmcdocument of 5 observationsDOI 10.1371/journal.pone.0209966
Gold tier: mechanically validated evidence, with its primary source.
1,197 evidence items · page 37 / 48
40.7 %The blood groups phenotypes O (40.7%) and A (31.2%) were more frequent with respective allele frequencies of 0.65 and 0.21.
Malipaludismepublished 2019PloS oneeurope_pmcdocument of 5 observationsDOI 10.1371/journal.pone.0209966
1.688 per_1000_person_weeksThe malaria outbreak that occurred in Kidal region between week 23 of 2024 and week 5 of 2025 was characterized by a very high incidence of 1.688 per 1,000 person-weeks.
Malipaludismeobserved week 23 of 2024 to week 5 of 2025HAL · Unilimdocument of 80 observations
99.5 %The day-42 PCR-adjusted cure rate estimates were 99.5% in the artesunate-amodiaquine arm.
Malipaludismepublished 2018Malaria journaleurope_pmcdocument of 9 observations
18.21 per_1000En 2020, l'incidence du paludisme pendant la grossesse était de 18,21 pour 1000 femmes au Mali.
Malipaludismeobserved 2020HAL · Unilimdocument of 302 observations
1,561 casesOver the whole period, 1561 cases of malaria were treated by mobile health teams.
MalipaludismeHAL · Unilimdocument of 80 observations
7,500,000,000 USDThe annual funding target for malaria control is $7.5 billion.
MalipaludismeHAL · Unilimdocument of 111 observations
14.2 %Le nombre de porteurs de gamétocytes représentait 14,2 % des participants.
MalipaludismeHAL · Unilimdocument of 214 observations
76 %Cassia sieberiana était principalement utilisée contre les douleurs gastriques, avec une fréquence d'utilisation de 76 %.
Malidouleurs gastriquesHAL · Unilimdocument of 20 observations
13.8 %The reinfection rate was 13.8% in the artesunate-amodiaquine arm.
Malipaludismepublished 2018Malaria journaleurope_pmcdocument of 9 observations
368.9 IU/mLThree priming doses of RTS,S/AS01 E induced a strong anti-CSP antibody response with a geometric mean titre of 368.9 IU/mL.
Malipaludismepublished 2025NPJ vaccineseurope_pmcdocument of 3 observations
12.95 timesPersons with diagnosed diabetes consumed 12.95 times more days of inpatient treatment than matched comparison subjects without diabetes in Cameroon, Mali, Tanzania and South Africa during 2008–2009.
Afrique du Sud · Cameroun · Mali · Tanzaniediabète (non précisé)observed 2008–2009published 2014PloS oneeurope_pmcdocument of 3 observations
1,647 episodesGastrointestinal infections occurred in 1647 episodes in the azithromycin group and 1985 episodes in the placebo group.
Burkina Faso · Maligastrointestinal infectionspublished 2019The New England journal of medicineeurope_pmcdocument of 4 observations
5.2 %In the pre-COVID-19 sample group (N = 283), the prevalence of antibody responders against RBM was 5.2% among males.
MaliSARS-CoV-2 RBMHAL · Unilimdocument of 67 observations
41.1 %Deaths excluding external causes or surgery were reduced by 41.1% in the combined RTS,S/AS01 E and SMC group compared with the SMC alone group.
Malipaludismepublished 2024The Lancet. Infectious diseaseseurope_pmcdocument of 12 observationsDOI 10.1016/s1473-3099(23)00368-7
62,315 casesIn 2025, a total of 62,315 cases (12,909 confirmed; 156 probable; 49,250 suspected) and 139 deaths (CFR: 0.22%) of dengue fever have been reported from 11 AU MS: Burkina Faso, Cabo Verde, Comoros, Guinea, Kenya, Mali, Mauritania, Mauritius, Nigeria, Senegal, and Sudan.
Burkina Faso · Guinée · Kenya · Mali · Mauritanie · Nigeria · Sénégal · Soudandengueobserved 2025Africa CDCdocument of 6 observations
100 %The proportion of triple dhfr mutants was 100% in 2014.
Malipaludismeobserved 2014published 2025Malaria journaleurope_pmcdocument of 5 observations
95.22 %HemotypeSC® had a sensitivity of 95.22% (95% CI: 93.74–96.70) to detect sickle cell disease carrier status.
MalidrépanocytoseHAL · Unilimdocument of 103 observations
27 %In Mali, the non-adjusted estimate of ONNV prevalence is 27%.
MaliO'nyong-nyong viruspublished 2021Nature communicationseurope_pmcdocument of 6 observations
2.6 %The prevalence rate of Plasmodium ovale was 2.6% in the Dogon population.
Malipaludismepublished 2017PloS oneeurope_pmcdocument of 14 observationsDOI 10.1371/journal.pone.0189724
84 %These health districts account for 84% of the population at risk of malaria and 92% of confirmed malaria cases.
MalipaludismeHAL · Unilimdocument of 95 observations
21.7 %In Mali, malaria prevalence among pregnant women at first antenatal care visit was 21.7% (284 of 1308).
Malipaludismeobserved between May, 2010, and August, 2014PubMeddocument of 8 observations
0.47 %Le taux de co-infection mixte par Plasmodium malariae et Plasmodium ovale était de 0,47 %.
MalipaludismeHAL · Unilimdocument of 31 observations
98.18 %The specificity of HemotypeSC® for detecting sickle cell trait was 98.18% (95% CI: 97.69–98.67).
Malitrait drépanocytaireHAL · Unilimdocument of 103 observations
0.1 %0,10 % des enfants âgés de moins de 1 an présentant une hyper-parasitémie (≥200 000 parasites/μL) avaient un intervalle de confiance à 95 % de 0,07 à 0,17 %.
MalipaludismeHAL · Unilimdocument of 214 observations
165,000,000 casEntre 2020 et 2021, le nombre de cas de paludisme dans les pays les plus touchés est passé de 165 millions à 168 millions.
Malipaludismeobserved 2020 à 2021HAL · Unilimdocument of 214 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.